For example, N-phthaloyl-l-tryptophan 1 (RG108), a DNMT1 inhibitor, and its maleimide derivatives can be considered as potential agents for the treatment of atherosclerosis and CAD [314,315]. This evidence concerns the gene DNMT1 and atherosclerosis.